Cargando…
Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats
There is an urgent need for a vaccine to prevent chronic infection by hepatitis C virus (HCV) and its many genetic variants. The first human vaccine trial, using recombinant viral vectors that stimulate pan-genotypic T cell responses against HCV non-structural proteins, failed to demonstrate efficac...
Autores principales: | Hartlage, Alex S., Dravid, Piyush, Walker, Christopher M., Kapoor, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009437/ https://www.ncbi.nlm.nih.gov/pubmed/33735321 http://dx.doi.org/10.1371/journal.ppat.1009391 |
Ejemplares similares
-
Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection
por: Hartlage, Alex S., et al.
Publicado: (2019) -
Phenotype and fate of liver-resident CD8 T cells during acute and chronic hepacivirus infection
por: Dravid, Piyush, et al.
Publicado: (2023) -
303. A Surrogate Rodent Model for Studying Hepatitis C Virus-specific CD8 T-cell Impairment and Vaccine Prevention
por: Hartlage, Alex S, et al.
Publicado: (2019) -
Nonprimate Hepaciviruses in Domestic Horses, United Kingdom
por: Lyons, Sinéad, et al.
Publicado: (2012) -
The evolutionary history of hepaciviruses
por: Li, YQ, et al.
Publicado: (2023)